NEVVI Medicare utilization intelligence

← back

Provider profile

GRACIA, CHELSEY D.O.

Pathology · NPI 1801201967 · BANGOR, ME

1
Groups
20
Codes · 2024
2,001
Disclosed services

GRACIA, CHELSEY is a Pathology in BANGOR, ME, a member of 1 medical group, who billed 20 distinct codes to Medicare Part B in 2024.

Groups: DAHL CHASE PATHOLOGY ASSOCIATES PA (BANGOR, ME)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

2,001
disclosed services
20
codes billed to Medicare Part B
Prior year · CY2023 1,873 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
88341 Special stained specimen slides to examine tissue, each additional procedure premiumpremium premiumpremium
88305 Pathology examination of tissue using a microscope, intermediate complexity premiumpremium premiumpremium
88377 Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure premiumpremium premiumpremium
88342 Special stained specimen slides to examine tissue, initial procedure premiumpremium premiumpremium
88313 Special stained specimen slides to examine tissue including interpretation and report premiumpremium premiumpremium
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers premiumpremium premiumpremium
G0452 Molecular pathology procedure; physician interpretation and report premiumpremium premiumpremium
88381 Preparation of specimen, manual premiumpremium premiumpremium
85060 Blood smear interpretation by physician with written report premiumpremium premiumpremium
88360 Microscopic genetic analysis of tumor, manual premiumpremium premiumpremium
88307 Pathology examination of tissue using a microscope, moderately high complexity premiumpremium premiumpremium
88311 Preparation of tissue for examination by removing any calcium present premiumpremium premiumpremium
85097 Bone marrow, smear interpretation premiumpremium premiumpremium
88365 Genetic sequencing localization, initial procedure premiumpremium premiumpremium
88364 Genetic sequencing localization, each additional procedure premiumpremium premiumpremium
88304 Pathology examination of tissue using a microscope, moderately low complexity premiumpremium premiumpremium
88344 Special stained specimen slides to examine tissue, each multiplex procedure premiumpremium premiumpremium
88368 Microscopic genetic analysis of tissue, manual, initial procedure premiumpremium premiumpremium
88108 Cell examination of specimen, concentration technique premiumpremium premiumpremium
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.